Login / Signup

The experience of diagnosis and treatment for TAFRO syndrome.

Xiaolong WuXudong ZhangSiyu QianCunzhen ShiXin LiXiaoyan FengLinan ZhuJingjing GeZhaoming LiMing-Zhi Zhang
Published in: Annals of hematology (2023)
Early identification, diagnosis and treatment of TAFRO syndrome are very importants. We retrospectively analysed 6 patients with TAFRO syndrome. Their clinical manifestations, treatment methods, survival and other aspects were summarized. All patients were pathologically diagnosed with Castleman's disease, with fever, an inflammatory storm state and varying degrees of anasarca. All patients received steroid therapy; four of them also received chemotherapy, and 1 received rituximab. Of the 3 patients with severe disease, only 1 patient who received the recommended dose of glucocorticoids survived. Early administration of glucocorticoids can improve the prognosis, especially in patients with severe disease, and adequate glucocorticoids are important.
Keyphrases
  • bioinformatics analysis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • case report
  • prognostic factors
  • stem cells
  • diffuse large b cell lymphoma
  • drug induced
  • smoking cessation
  • cell therapy
  • free survival